Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.

× No keyword cloud information.

11 in total

1. THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

Authors: H KEBERLE
Journal: Ann N Y Acad Sci Date: 1964-10-07 Impact factor: 5.691

2. Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.

Authors: E J Fudman; G O Till; I H Fox
Journal: J Rheumatol Date: 1987-08 Impact factor: 4.666

3. Concentration of iron in synovial membrane, synovial fluid, and serum in rheumatoid arthritis and other joint diseases.

Authors: G B Senator; K D Muirden
Journal: Ann Rheum Dis Date: 1968-01 Impact factor: 19.103

4. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.

Authors: A Sato; P E Bacon; J G Cory
Journal: Adv Enzyme Regul Date: 1984

5. The importance of iron in rheumatoid disease.

Authors: D R Blake; N D Hall; P A Bacon; P A Dieppe; B Halliwell; J M Gutteridge
Journal: Lancet Date: 1981-11-21 Impact factor: 79.321

6. Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus.

Authors: J Font; A Coca; R Molina; A Ballesta; F Cardellach; M Ingelmo; A Balague; A Balcells
Journal: Scand J Rheumatol Date: 1986 Impact factor: 3.641

7. Effect of iron chelation on inflammatory joint disease.

Authors: F J Andrews; C J Morris; G Kondratowicz; D R Blake
Journal: Ann Rheum Dis Date: 1987-04 Impact factor: 19.103

8. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients.

Authors: D Rowley; J M Gutteridge; D Blake; M Farr; B Halliwell
Journal: Clin Sci (Lond) Date: 1984-06 Impact factor: 6.124

9. Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis.

Authors: N Giordano; S Sancasciani; C Borghi; A Fioravanti; R Marcolongo
Journal: Clin Exp Rheumatol Date: 1986 Jan-Mar Impact factor: 4.473

10. Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis.

Authors: D Manicourt; H Brauman; S Orloff
Journal: Ann Rheum Dis Date: 1978-08 Impact factor: 19.103

4 in total

1. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

Authors: H R Peeters; M Jongen-Lavrencic; G Vreugdenhil; A J Swaak
Journal: Ann Rheum Dis Date: 1996-10 Impact factor: 19.103

2. Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis.

Authors: C Salvarani; R Baricchi; D Lasagni; L Boiardi; R Piccinini; C Brunati; P Macchioni; I Portioli
Journal: Rheumatol Int Date: 1996 Impact factor: 2.631

3. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice.

Authors: Lijian Wang; Lynne Harrington; Estela Trebicka; Hai Ning Shi; Jonathan C Kagan; Charles C Hong; Herbert Y Lin; Jodie L Babitt; Bobby J Cherayil
Journal: J Clin Invest Date: 2009-10-05 Impact factor: 14.808

Review 4. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

Authors: Etheresia Pretorius; Oore-Ofe Akeredolu; Prashilla Soma; Douglas B Kell
Journal: Exp Biol Med (Maywood) Date: 2016-11-26

4 in total